Introduction
Objectives
-Discuss Unmet Needs in AD: Review Evolving Diagnosis of AD and Biomarker
-Explore the Benefits of Timely and Accurate AD Diagnosis Based on the Combination of Clinical
and Biomarker Assessment (PET, CSF and Blood) in Real World Practice
-Understand the Estimated Cost Associated with Diagnosis and the Gap in Coverage for PET
-Explore the Rationale to Capacity Plan for the Growth in Utilization of AD Diagnostic Modalities
This Course For :
Clinical Pharmacy
Pharmacy
Speaker
Grazia Dell' Agnell
Associate VP, International Medical Affairs, Eli Lilly.
Prof. Taoufik Alsaadi
Chief Medical Officer and the Chair of the Neurology Department, American Center for Psychiatry & Neurology (ACPN).
Prof.Fabrizio Gardoni
Full Professor of Pharmacology Lab. Pharmacology of Neurodegeneration, Dept. Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", University of Milano.
Dr. Félix Rubial Bernárdez
General Manager Integrated Healthcare Organization of Ourense, Verín & O Barco de Valdeorras, Galician Health Service.
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
27 Feb 2024 To 27 Feb 2024 -
08:00 PM To 09:00 PM 
Certificate Available 
Online Click Here
- 232
Add to Calendar
02/27/2024 08:00 PM
02/27/2024 09:00 PM
Asia/ Riyadh
Planning for Timely & Accurate Diagnosis of Alzheimer's Disease
Planning for Timely & Accurate Diagnosis of Alzheimer's Disease
https://medicalacademy.org/portal/event/view/2128
